ACUTE LEUKEMIA

This study tested whether a new, lab-expanded cord blood transplant (called NiCord) works better than a standard cord blood transplant for patients with blood cancers like leukemia and lymphoma. The goal was to see if the expanded cells help patients recover their immune systems …

This study tested a new three-drug combination (PTCy, sirolimus, and VIC-1911) to prevent two major problems after a stem cell transplant: graft-versus-host disease (GVHD) and cancer relapse. It involved 16 adults with blood cancers like leukemia and lymphoma who received a high-…

This study tested if a drug called palifermin, given before a stem cell transplant, could make the procedure safer and more effective. It involved 34 adults with blood cancers who received stem cells from an unrelated, matched donor. The main goals were to find a safe dose and se…

This study tested whether relaxing aesthetic care sessions could help patients feel better during difficult hospital stays. It involved 70 adults with acute leukemia or receiving a stem cell transplant, who had to stay in a protected isolation room for weeks. Researchers used que…

This completed study aimed to understand how blood clotting factors differ in people with acute leukemia. Researchers measured four specific clotting-related substances in 90 participants—60 with leukemia and 30 healthy people—to compare their levels. The goal was to gather knowl…